IndusLaw advised BRLMs on the deal. Concord Biotech issued Equity Shares aggregating up to ?15,505.21 million (USD 186.58 million). Kotak Mahindra Capital Company Limited, Citigroup Global Markets...
This content is for Standard 1 Year members only. LoginJoin Now